Annual Report to the Nation: Patient economic burden of cancer care over $21B

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Part two of the latest Annual Report to the Nation on the Status of Cancer found that in 2019, the national patient economic burden associated with cancer care was $21.09 billion, made up of patient out-of-pocket costs of $16.22 billion and patient time costs—the value of time that patients spend traveling to and from, waiting for, and receiving care—of $4.87 billion. 

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

People of African ancestry (Black/African American) have some of the worst cancer incidence and greatest mortality, compared to white and other racial and ethnic populations in the U.S. On average, Black persons are 1.5 times more likely to have cancer and >2X more likely to die from cancer compared to whites. xxx:more

Login